Biotech & Healthcare Archives - Vista Partners LLC

Record Highs for Dow and S&P 500: Eli Lilly Shines, Oracle Sinks AI Sentiment This Week – December 12, 2025 -( $LLY $MCD $NOK $PL $PLTR $RIO $TSLA Rise!)

by Vista Partners LLC 2 days ago 1838Views 0Likes

Wall Street limped into the weekend looking like a marathoner who realized the finish line had quietly moved 100 yards farther away: still standing, but with the AI high-fliers suddenly short of breath and old‑economy cyclicals enjoying a late‑season second wind. Indexes:…

Eupraxia Pharmaceuticals: The Small‑Cap Biotech Quietly Seeking To Build a Billion‑Dollar Plus EoE Franchise -( $EPRX $IBB $XBI )

by Vista Partners LLC 3 days ago 220Views 0Likes

Eupraxia Pharmaceuticals (NASDAQ: EPRX, $6.40, +1.59% today and +85.51% over the last year) is emerging as a standout small‑cap biotech, transforming a once‑niche GI indication and routine endoscopy visits into a compelling, scalable growth platform, underpinned by a mid‑teens price target from…

Dow and S&P 500 Hit New Highs While Tech Wobbles: Tariffs, Fed Cuts, and IPOs Shape December 11, 2025 Trading -( $EPRX $LMRI $MODD $NOK $OKLO $OPEN $PL $RIO $SOAR Rise!)

by Vista Partners LLC 3 days ago 1781Views 0Likes

Wall Street ended Thursday with the Dow and S&P 500 looking like they’d just discovered compound interest, while the Nasdaq nursed an AI hangover and small caps quietly joined the advance. The Dow Jones Industrial Average surged about 1.3% to a fresh…

Modular Medical Bets on ~$3B Market for “Almost-Pumpers,” Taps Wall Street to Fuel Next-Gen Insulin Patch Pumps -( $MODD )

by Vista Partners LLC 3 days ago 274Views 0Likes

In a season when most micro-cap CEOs are more focused on keeping the lights on than rewriting the diabetes playbook, Modular Medical (MODD) is trying to do both – and pass the hat on Wall Street at the same time. The San…

Rate Cuts, Curves and Chips: How the Fed’s Quarter-Point Trim Reshaped Wednesday’s Tape – December 10, 2025 -( $AAPL $ABVX $AVGO $DV $EPRX $INTC $INTG $LLY $NOK $PLTR $RIO $TSLA $TSM Rise!)

by Vista Partners LLC 4 days ago 1671Views 0Likes

Markets leaned into the Fed’s latest cut with the kind of cautious enthusiasm usually reserved for a long‑overdue bonus. Major indexes U.S. stocks spent Wednesday strutting rather than sprinting, as the S&P 500 rose about 0.7% to roughly 6,887, just shy of…

Inside GeoVax’s Big-League Scientific Upgrade: Global Experts Join the Fight Against Cancer and Deadly Viruses -( $GOVX $AZN $IBB $XBI )

by Vista Partners LLC 4 days ago 280Views 0Likes

GeoVax’s (NASDAQ: GOVX) latest boardroom move reads like a biotech who’s-who casting call, with the Atlanta-based vaccine developer quietly assembling a scientific brain trust that looks less like a small-cap advisory board and more like a Davos side panel on immunology. A…

The Year of the Bispecific: Biotech’s Double-Edged Breakout -( $ARKG $IBB $XBI $RHBBY $AMGN $JNJ )

by Vista Partners LLC 4 days ago 74Views 0Likes

If 2024 crowned weight-loss drugs the belle of the healthcare ball, 2025 belongs to the bispecific antibody. What began as a niche in immuno-oncology has evolved into biotech’s most competitive—and potentially lucrative—battleground, drawing fresh capital, dealmaking, and analyst optimism that borders on…

S&P 500, Dow, Nasdaq & Russell Diverge as Fed Decision Looms, Silver Hits Record and M&A Heats Up – December 9, 2025 -( $INTC $MODD $NOK $OPEN $ORCL $PLTR $RIO $SOAR $TSLA $TSM Rise!)

by Vista Partners LLC 5 days ago 1468Views 0Likes

Wall Street spent Tuesday marking time and watching the clock, as markets drifted in tight formation ahead of Wednesday’s Fed decision, with just enough sector rotation and deal drama to keep traders from checking out entirely. Indexes and macro tone The major…

Wall Street Opens Fed Week on Edge as Paramount’s $108 Billion Hollywood Gambit Steals the Show – December 8, 2025 -( $AVGO $DV $GOVX $NOK $NVDA $ORCL $PKSY $TSM $WBD Rise!)

by Vista Partners LLC December 8, 2025 1409Views 0Likes

Wall Street opened the week in a cautious mood Monday, with the major averages edging lower as investors stared down a data‑thin calendar and a Fed meeting that promises more intrigue than drama. The Dow Jones Industrial Average slipped around six‑tenths of…

GeoVax Takes Aim at Tumor Microenvironments as Gedeptin Data Hit JCO Oncology Advances -( $GOVX $IBB $XBI )

by Vista Partners LLC December 8, 2025 202Views 0Likes

GeoVax’s (NASDAQ: GOVX) latest cameo in JCO Oncology Advances reads like the opening argument for an oncology re-rate, with its gene-directed cancer therapy Gedeptin now backed by human data that suggest the platform is more than clever lab work. For a company many investors…

Biotech & Healthcare

Your Guide To Staying Informed In The Markets